Global Drug Repurposing Service Providers Market Research Report 2020-2030

Presently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry; interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots Analysis

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles of such candidates have already been established).

Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.”

The USD 1.2 billion (by 2030) financial opportunity within the drug repurposing service providers market has been analyzed across the following segments:

Type of Repurposing Approaches

Therapeutic Area

Type of Drug Molecule

Key Geographical Region

The Drug Repurposing Service Providers Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

Table of Contents

For more informationBusiness Management Articles, please click on the following link:

https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html    

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]

 

Rejected Everywhere For A Merchant Account? We have a solution! Low – High-Risk Merchant Account Specialists. Unlimited Processing at 0%. No Contracts. No Shut Downs. No Set-Up & Application Fees. FREE Gateway Set-Up – Secured Transactions.

Open a New Merchant Account Here Now – OPEN MERCHANT ACCOUNT. PAYMENTS – PERFECTED.

Leave a Reply

Your email address will not be published.